International Session (Symposium)1 (JSH, JSGE)

Understanding the immune microenvironment of liver cancer and its application to personalized medicine

• Chairperson:
  Shinji TanakaDepartment of Molecular Oncology, Graduate School of Medicine, Institute of Science Tokyo
• Chairperson:
  Takahiro KodamaDepartment of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine

IS-S1-Keynote Lecture
Deciphering the Immune Microenvironment of Liver Cancer: From Mechanisms to Personalized Medicine

IS-S1-1_H
Regression Model for Predicting the Glycolysis-Driven-HCC Subclass

IS-S1-2_G
Hepatocellular carcinoma microenvironment analysis using single-cell RNA-seq to search for immunotherapy-sensitive subtypes

IS-S1-3_H
Spatial mapping of pre-cancerous fibrosis niche of the chronic hepatitis B

IS-S1-4_H
CXCR4-Positive Antigen-Presenting Cancer-Associated Fibroblasts Identified by Spatial Transcriptomics as Immune Barriers in Hepatocellular Carcinoma Outstanding Award

IS-S1-5_H
Spatial Transcriptomic Profiling Identifies a Predictive Biomarker for Non-Response to Atezolizumab Plus Bevacizumab in HCC

IS-S1-6_H
Spatial CD8+ T Cell Distribution as a Predictive Biomarker for Atezolizumab Plus Bevacizumab Efficacy in Advanced Hepatocellular Carcinoma

IS-S1-7_H
Biomarker identification and potential combination therapy targeting chemokine changes after atezolizumab plus bevacizumab treatment in unresectable hepatocellular carcinoma

IS-S1-8_H
PD-L1(+) Macrophages Activated by Tumor-Derived GM-CSF Induce CD8(+) T Cell Exhaustion in Hepatocellular Carcinoma Outstanding Award

IS-S1-9_H
Elucidation of the mechanism of malignant progression in the Lenvatinib-resistant hepatocellular carcinoma microenvironment

International Session (Symposium)2 (JSGE, JGES, JSGS)

Current and future development of IBD treatment with multiple options

• Chairperson:
  Takanori KanaiDepartment of Gastroenterology and Hepatology, Keio University School of Medicine
• Chairperson:
  Kiichiro TsuchiyaDepartment of Gastroenterology, University of Tsukuba

IS-S2-Keynote Lecture
Optimal treatment sequencing in inflammatory bowel disease

IS-S2-1_G
JAK Inhibitors and Herpes Zoster in UC: Genetic Insights for Safer Treatment Strategies

IS-S2-2_G
Thromboembolic Risk in Ulcerative Colitis Patients on Advanced Therapy

IS-S2-3_G
Recurrence Routes - Mapping Anastomotic Outcomes in Ileocolic Crohn's Disease in a Metropolitan Hospital

IS-S2-4_S
Long-term treatment strategy for Crohn's disease anal fistula

IS-S2-5_G
Early Consideration from our agency: "Points to Consider in the Development of Drugs for Pediatric Inflammatory Bowel Disease"

IS-S2-6_G
A Treatment Selection Model for Ulcerative Colitis Integrating LRG and Fuc-proHp, an IL-6-Independent Biomarker

IS-S2-7_G
Evaluating the Optimal Treatment Sequence After Vedolizumab Failure in Ulcerative Colitis

IS-S2-8_G
Study on the prognosis of patients with remitting ulcerative colitis after discontinuation of indigo naturalis

IS-S2-9_G
Understanding the Shift in Ulcerative Colitis Therapy Sequences Across Diagnostic Era: A Multicenter Retrospective I-BRITE Study

IS-S2-10_G
Lower Quality of Life Contributes to Presenteeism in Patients with Crohn's Disease in Remission

International Session (Symposium)3 (JSGS)

Current status and future perspectives in robotic surgery in Asia

• Chairperson:
  Koichi SudaDivisions of GI & HPB, Department of Surgery, Fujita Health University
• Chairperson:
  Masashi TsurutaDepartment of HBP & GI Surgery, International University of Health and Welfare

IS-S3-Keynote Lecture
Current status and future perspectives in robotic surgery in Asia

IS-S3-1_S
RESULTS OF 3D THORACO-LAPAROSCOPIC ESOPHAGECTOMY FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA AT VIETNAM NATIONAL CANCER HOSPITAL

IS-S3-2_S
Robotic assisted Upper GI cancer surgery with Novel Sentire System

IS-S3-3_S
Comparison of minimally invasive gastrectomy outcomes between a university hospital and a general hospital: Evaluating the utility of robot-assisted gastrectomy

IS-S3-4_S
Robotic Surgery for Gastric Cancer: from Japan toward Asia and the World

IS-S3-5_S
Advancing Robotic Colorectal Surgery in Asia: The Intersection of Technology, Training, and Policy

IS-S3-6_S

IS-S3-7_S
The Future of Surgery Opened by Robotic-Assisted Techniques in Colorectal Cancer

IS-S3-8_S
Real-world hospital charges of robotic vs laparoscopic rectal surgery in a referral center in Japan: Cost breakdown analyses according to procedure

IS-S3-9_S
Future directions of robotic surgery in the Hepatobiliary and Pancreatic field including new robotic platforms

IS-S3-Special Remarks